OpenClinicalAI: enabling AI to diagnose diseases in real-world clinical settings

This paper quantitatively reveals the state-of-the-art and state-of-the-practice AI systems only achieve acceptable performance on the stringent conditions that all categories of subjects are known, which we call closed clinical settings, but fail to work in real-world clinical settings. Compared to the diagnosis task in the closed setting, real-world clinical settings pose severe challenges, and we must treat them differently. We build a clinical AI benchmark named Clinical AIBench to set up real-world clinical settings to facilitate researches. We propose an open, dynamic machine learning framework and develop an AI system named OpenClinicalAI to diagnose diseases in real-world clinical settings. The first versions of Clinical AIBench and OpenClinicalAI target Alzheimer's disease. In the real-world clinical setting, OpenClinicalAI significantly outperforms the state-of-the-art AI system. In addition, OpenClinicalAI develops personalized diagnosis strategies to avoid unnecessary testing and seamlessly collaborates with clinicians. It is promising to be embedded in the current medical systems to improve medical services.

[1]  M. van Assen,et al.  Artificial Intelligence: From Scientific Curiosity to Clinical Precocity? , 2019, JACC. Cardiovascular imaging.

[2]  Han-Mo Chiu,et al.  Application of artificial intelligence in gastroenterology: Potential role in clinical practice , 2021, Journal of gastroenterology and hepatology.

[3]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[4]  R. Murugan,et al.  FAF-DRVFL: Fuzzy activation function based deep random vector functional links network for early diagnosis of Alzheimer disease , 2021, Appl. Soft Comput..

[5]  Seunggyun Ha,et al.  Deep learning only by normal brain PET identify unheralded brain anomalies , 2019, EBioMedicine.

[6]  Yiming Ding,et al.  A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain. , 2019, Radiology.

[7]  Geraint Rees,et al.  Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.

[8]  Raymond Chiong,et al.  Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review , 2019, Comput. Methods Programs Biomed..

[9]  Michael V. McConnell,et al.  Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning , 2017, Nature Biomedical Engineering.

[10]  Arthur W. Toga,et al.  Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework , 2018, Neurobiology of Aging.

[11]  Mohammad Mansouri,et al.  An explainable deep-learning algorithm for the detection of acute intracranial haemorrhage from small datasets , 2018, Nature Biomedical Engineering.

[12]  Xiaoping Zhou,et al.  Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification , 2020, Brain : a journal of neurology.

[13]  Geoffrey E. Hinton,et al.  Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition-' Washington , D . C . , June , 1983 OPTIMAL PERCEPTUAL INFERENCE , 2011 .

[14]  Mirza Faisal Beg,et al.  Multiscale deep neural network based analysis of FDG‐PET images for the early diagnosis of Alzheimer's disease , 2018, Medical Image Anal..

[15]  Charu C. Aggarwal,et al.  Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining , 2016, KDD.

[16]  Brian D Nicholson,et al.  Overtesting and undertesting in primary care: a systematic review and meta-analysis , 2018, BMJ Open.

[17]  M. Kunitski,et al.  Double-slit photoelectron interference in strong-field ionization of the neon dimer , 2018, Nature Communications.

[18]  Christian Etmann,et al.  Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans , 2020 .

[19]  King-Sun Fu,et al.  IEEE Transactions on Pattern Analysis and Machine Intelligence Publication Information , 2004, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[20]  Nicola Thrupp,et al.  The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.

[21]  Alexandra Luccioni,et al.  Mapping the Landscape of Artificial Intelligence Applications against COVID-19 , 2020, J. Artif. Intell. Res..

[22]  Danni Cheng,et al.  Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images , 2018, Front. Neuroinform..

[23]  Alzheimer’s Association 2018 Alzheimer's disease facts and figures , 2018, Alzheimer's & Dementia.

[24]  L. Beckett,et al.  Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.

[25]  Christopher Mabey,et al.  Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial , 2017, The Lancet.

[26]  Stuart I. Herbert,et al.  Computer Methods and Programs in Biomedicine 48 (1995) 21-26 , 1995 .

[27]  Jie Xu,et al.  The practical implementation of artificial intelligence technologies in medicine , 2019, Nature Medicine.

[28]  Daniel S. Kermany,et al.  Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning , 2018, Cell.

[29]  David S. Melnick,et al.  International evaluation of an AI system for breast cancer screening , 2020, Nature.

[30]  Philip R. O. Payne,et al.  Questions for Artificial Intelligence in Health Care. , 2019, JAMA.

[31]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[32]  Marcus A. Badgeley,et al.  Automated deep-neural-network surveillance of cranial images for acute neurologic events , 2018, Nature Medicine.

[33]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[34]  John Paoli,et al.  Human–computer collaboration for skin cancer recognition , 2020, Nature Medicine.

[35]  A. Barratt,et al.  Global Media Coverage of the Benefits and Harms of Early Detection Tests. , 2021, JAMA internal medicine.

[36]  Z. Fayad,et al.  Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 , 2020, Nature Medicine.